Statistics

Total Visits

Views
Bendamustine in combination with rituximab as first-line treatment for indolent non-hodgkin lymphoma: Retrospective analysis of An Spanish registry30

Select a period of time:

Number of views in the range

Views
Bendamustine in combination with rituximab as first-line treatment for indolent non-hodgkin lymphoma: Retrospective analysis of An Spanish registry18

Views

Views
October 20240
November 20240
December 20241
January 20250
February 20250
March 202516
April 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Spain1
United Kingdom1
 

Top cities views

Views